Cargando…
Natural History of Vanishing White Matter
OBJECTIVE: To comprehensively describe the natural history of vanishing white matter (VWM), aiming at improving counseling of patients/families and providing natural history data for future therapeutic trials. METHODS: We performed a longitudinal multicenter study among 296 genetically confirmed VWM...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175238/ https://www.ncbi.nlm.nih.gov/pubmed/30014503 http://dx.doi.org/10.1002/ana.25287 |
_version_ | 1783361462825123840 |
---|---|
author | Hamilton, Eline M. C. van der Lei, Hannemieke D. W. Vermeulen, Gerre Gerver, Jan A. M. Lourenço, Charles M. Naidu, Sakkubai Mierzewska, Hanna Gemke, Reinoud J. B. J. de Vet, Henrica C. W. Uitdehaag, Bernard M. J. Lissenberg‐Witte, Birgit I. Research Group, VWM van der Knaap, Marjo S. |
author_facet | Hamilton, Eline M. C. van der Lei, Hannemieke D. W. Vermeulen, Gerre Gerver, Jan A. M. Lourenço, Charles M. Naidu, Sakkubai Mierzewska, Hanna Gemke, Reinoud J. B. J. de Vet, Henrica C. W. Uitdehaag, Bernard M. J. Lissenberg‐Witte, Birgit I. Research Group, VWM van der Knaap, Marjo S. |
author_sort | Hamilton, Eline M. C. |
collection | PubMed |
description | OBJECTIVE: To comprehensively describe the natural history of vanishing white matter (VWM), aiming at improving counseling of patients/families and providing natural history data for future therapeutic trials. METHODS: We performed a longitudinal multicenter study among 296 genetically confirmed VWM patients. Clinical information was obtained via disease‐specific clinical questionnaire, Health Utilities Index and Guy's Neurological Disability Scale assessments, and chart review. RESULTS: First disease signs occurred at a median age of 3 years (mode = 2 years, range = before birth to 54 years); 60% of patients were symptomatic before the age of 4 years. The nature of the first signs varied for different ages of onset. Overall, motor problems were the most common presenting sign, especially in children. Adolescent and adult onset patients were more likely to exhibit cognitive problems early after disease onset. One hundred two patients were deceased. Multivariate Cox regression analysis revealed a positive relation between age at onset and both preservation of ambulation and survival. Absence of stress‐provoked episodes and absence of seizures predicted more favorable outcome. In patients with onset before 4 years, earlier onset was associated with more severe disability and higher mortality. For onset from 4 years on, disease course was generally milder, with a wide variation in severity. There were no significant differences for sex or for the 5 eIF2B gene groups. The results confirm the presence of a genotype–phenotype correlation. INTERPRETATION: The VWM disease spectrum consists of a continuum with extremely wide variability. Age at onset is a strong predictor for disease course. Ann Neurol 2018;84:274–288 |
format | Online Article Text |
id | pubmed-6175238 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-61752382018-10-15 Natural History of Vanishing White Matter Hamilton, Eline M. C. van der Lei, Hannemieke D. W. Vermeulen, Gerre Gerver, Jan A. M. Lourenço, Charles M. Naidu, Sakkubai Mierzewska, Hanna Gemke, Reinoud J. B. J. de Vet, Henrica C. W. Uitdehaag, Bernard M. J. Lissenberg‐Witte, Birgit I. Research Group, VWM van der Knaap, Marjo S. Ann Neurol Research Articles OBJECTIVE: To comprehensively describe the natural history of vanishing white matter (VWM), aiming at improving counseling of patients/families and providing natural history data for future therapeutic trials. METHODS: We performed a longitudinal multicenter study among 296 genetically confirmed VWM patients. Clinical information was obtained via disease‐specific clinical questionnaire, Health Utilities Index and Guy's Neurological Disability Scale assessments, and chart review. RESULTS: First disease signs occurred at a median age of 3 years (mode = 2 years, range = before birth to 54 years); 60% of patients were symptomatic before the age of 4 years. The nature of the first signs varied for different ages of onset. Overall, motor problems were the most common presenting sign, especially in children. Adolescent and adult onset patients were more likely to exhibit cognitive problems early after disease onset. One hundred two patients were deceased. Multivariate Cox regression analysis revealed a positive relation between age at onset and both preservation of ambulation and survival. Absence of stress‐provoked episodes and absence of seizures predicted more favorable outcome. In patients with onset before 4 years, earlier onset was associated with more severe disability and higher mortality. For onset from 4 years on, disease course was generally milder, with a wide variation in severity. There were no significant differences for sex or for the 5 eIF2B gene groups. The results confirm the presence of a genotype–phenotype correlation. INTERPRETATION: The VWM disease spectrum consists of a continuum with extremely wide variability. Age at onset is a strong predictor for disease course. Ann Neurol 2018;84:274–288 John Wiley and Sons Inc. 2018-09-06 2018-08 /pmc/articles/PMC6175238/ /pubmed/30014503 http://dx.doi.org/10.1002/ana.25287 Text en © 2018 The Authors. Annals of Neurology published by Wiley Periodicals, Inc. on behalf of American Neurological Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Hamilton, Eline M. C. van der Lei, Hannemieke D. W. Vermeulen, Gerre Gerver, Jan A. M. Lourenço, Charles M. Naidu, Sakkubai Mierzewska, Hanna Gemke, Reinoud J. B. J. de Vet, Henrica C. W. Uitdehaag, Bernard M. J. Lissenberg‐Witte, Birgit I. Research Group, VWM van der Knaap, Marjo S. Natural History of Vanishing White Matter |
title | Natural History of Vanishing White Matter |
title_full | Natural History of Vanishing White Matter |
title_fullStr | Natural History of Vanishing White Matter |
title_full_unstemmed | Natural History of Vanishing White Matter |
title_short | Natural History of Vanishing White Matter |
title_sort | natural history of vanishing white matter |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175238/ https://www.ncbi.nlm.nih.gov/pubmed/30014503 http://dx.doi.org/10.1002/ana.25287 |
work_keys_str_mv | AT hamiltonelinemc naturalhistoryofvanishingwhitematter AT vanderleihannemiekedw naturalhistoryofvanishingwhitematter AT vermeulengerre naturalhistoryofvanishingwhitematter AT gerverjanam naturalhistoryofvanishingwhitematter AT lourencocharlesm naturalhistoryofvanishingwhitematter AT naidusakkubai naturalhistoryofvanishingwhitematter AT mierzewskahanna naturalhistoryofvanishingwhitematter AT gemkereinoudjbj naturalhistoryofvanishingwhitematter AT devethenricacw naturalhistoryofvanishingwhitematter AT uitdehaagbernardmj naturalhistoryofvanishingwhitematter AT lissenbergwittebirgiti naturalhistoryofvanishingwhitematter AT researchgroupvwm naturalhistoryofvanishingwhitematter AT vanderknaapmarjos naturalhistoryofvanishingwhitematter |